Login
Login     |     Register     |     Recover Username/Password

General Investing

Income Stability Is Key To Insurers’ Reserve Adequacy

July 13, 2012

Investors should look to insurance companies with more stable income due to uncertainty over how long favorable reserve development in the industry is expected to continue, says Robert Farnam, a Senior Vice President at Keefe, Bruyette & Woods, Inc.

“Workers’ compensation is actually a line, one of the largest commercial lines, and I think that that line is deficient. So you’ve already started to see some companies reporting adverse development there,” he said. “A lot of the commercial lines, I think, kind of the casualty lines, have questionable reserve adequacy, which could lead to adverse development going forward.”

Farnam has an “outperform” rating on Maiden Holdings, Ltd. (MHLD), a smaller Bermuda reinsurance company. He says the benefit of Maiden is that it’s different from other Bermuda reinsurance companies because it does not write property catastrophe risk, so its earnings are more stable.

“Their issue right now is that they are still sitting on too much cash. I think they still have to try to put that to work in this weak environment though. But stability is the key for them,” Farnam said. “I think they haven’t had a combined ratio out of the 90s since they’ve been in existence. So I think it’s attractively valued relative to what its performance expectations are.”


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now